Literature DB >> 6170735

Antibiotics and antivirals do not modify experimentally-induced Creutzfeldt-Jakob disease in mice.

J Tateishi.   

Abstract

Thiamphenicol, rifampicin, amantadine, cytosine arabinoside and isoprinosine were administered to mice which were inoculated with brain tissue containing Creutzfeldt-Jakob disease (CJD). All the mice developed disease within 3 to 6 months after inoculation. As there was no significant shift in incubation periods among animal groups of each drug administration and non-administration, these compounds had no effect in controlling experimental CJD.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170735      PMCID: PMC491093          DOI: 10.1136/jnnp.44.8.723

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Transmission of Creutzfeldt-Jakob disease to guineapigs.

Authors:  W B Matthews; A H Thomlinson; J T Hughes
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

2.  Creutzfeldt-Jakob disease treated with amantidine. A report of two cases.

Authors:  W L Sanders; T L Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

3.  Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee.

Authors:  C J Gibbs; D C Gajdusek; D M Asher; M P Alpers; E Beck; P M Daniel; W B Matthews
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

4.  Experimental transmission of human subacute spongiform encephalopathy to small rodents. I. Clinical and histological observations.

Authors:  J Tateishi; Y Sato; M Koga; H Doi; M Ohta
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  Creutzfeldt-Jakob disease treated with amantadine.

Authors:  W L Sanders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

6.  Experimental transmission of human subacute spongiform encephalopathy to small rodents. III. Further transmission from three patients and distribution patterns of lesions in mice.

Authors:  J Tateishi; H Doi; Y Sato; M Suetsugu; K Ishii; Y Kuroiwa
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

  6 in total
  4 in total

1.  The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.

Authors:  R H Kimberlin; C A Walker
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 2.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

Review 3.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

Review 4.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.